Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erberto Carluccio

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Therapeutic Advances in Cardiovascular Disease|November 29, 2024
Effects of sacubitril/valsartan on renal function and outcome in patients with heart failure and reduced ejection fraction: an Italian cohort studyAlberto Palazzuoli, Filippo Pirrotta, Alessandra Cartocci, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 21, 2023
Effect of sacubitril/valsartan on cardiac remodeling compared with other renin-angiotensin system inhibitors: a difference-in-difference analysis of propensity-score matched samplesErberto Carluccio, Frank L Dini, Michele Correale, et al.
European Journal of Heart Failure|September 9, 2017
Risk stratification of Asian patients with heart failure and reduced ejection fraction: the effectiveness of the Echo Heart Failure ScoreLena Bosch, Erberto Carluccio, Stefano Coiro, et al.
ESC Heart Failure|April 16, 2025
Right ventricular strain predicts outcome in patients receiving sacubitril/valsartan: A sub-analysis of DISCOVER-ARNIMaria Concetta Pastore, Giulia Elena Mandoli, Alberto Giannoni, et al.
Frontiers in Cardiovascular Medicine|May 27, 2024
Effects of sacubitril/valsartan on the functional capacity of real-world patients in Italy: the REAL.IT study on heart failure with reduced ejection fractionFilippo Maria Sarullo, Cinzia Nugara, Silvia Sarullo, et al.
ESC Heart Failure|July 11, 2024
Eligibility for vericiguat in a real-world, contemporary heart failure populationGiuseppe Vergaro, Alberto Aimo, Francesco Gentile, et al.
The American Journal of Cardiology|March 1, 2026
Prognostic thresholds of pulmonary artery pressure and right ventricular function at echocardiography in heart failureStefano Ghio, Erberto Carluccio, Monica Franzese, et al.
Heart Rhythm|December 7, 2025
Effectiveness and safety of upgrading to conduction system pacing compared with biventricular pacing in patients with pacing-induced cardiomyopathy: Results of a propensity score-matched analysis from a multicenter registryPietro Palmisano, Gabriele Dell'Era, Matteo Ziacchi, et al.
Heart Failure Reviews|November 17, 2022
Right heart failure in left heart disease: imaging, functional, and biochemical aspects of right ventricular dysfunctionStefano Ghio, Mauro Acquaro, Piergiuseppe Agostoni, et al.
ESC Heart Failure|March 17, 2026
Long-term outcomes following Sacubitril/Valsartan therapy for chronic HFrEF. Italian Real-World Multicenter StudyGiuseppe Dattilo, Roberto Licordari, Egidio Imbalzano, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Therapeutic Advances in Cardiovascular Disease|November 29, 2024
Effects of sacubitril/valsartan on renal function and outcome in patients with heart failure and reduced ejection fraction: an Italian cohort studyAlberto Palazzuoli, Filippo Pirrotta, Alessandra Cartocci, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 21, 2023
Effect of sacubitril/valsartan on cardiac remodeling compared with other renin-angiotensin system inhibitors: a difference-in-difference analysis of propensity-score matched samplesErberto Carluccio, Frank L Dini, Michele Correale, et al.
European Journal of Heart Failure|September 9, 2017
Risk stratification of Asian patients with heart failure and reduced ejection fraction: the effectiveness of the Echo Heart Failure ScoreLena Bosch, Erberto Carluccio, Stefano Coiro, et al.
ESC Heart Failure|April 16, 2025
Right ventricular strain predicts outcome in patients receiving sacubitril/valsartan: A sub-analysis of DISCOVER-ARNIMaria Concetta Pastore, Giulia Elena Mandoli, Alberto Giannoni, et al.
Frontiers in Cardiovascular Medicine|May 27, 2024
Effects of sacubitril/valsartan on the functional capacity of real-world patients in Italy: the REAL.IT study on heart failure with reduced ejection fractionFilippo Maria Sarullo, Cinzia Nugara, Silvia Sarullo, et al.
ESC Heart Failure|July 11, 2024
Eligibility for vericiguat in a real-world, contemporary heart failure populationGiuseppe Vergaro, Alberto Aimo, Francesco Gentile, et al.
The American Journal of Cardiology|March 1, 2026
Prognostic thresholds of pulmonary artery pressure and right ventricular function at echocardiography in heart failureStefano Ghio, Erberto Carluccio, Monica Franzese, et al.
Heart Rhythm|December 7, 2025
Effectiveness and safety of upgrading to conduction system pacing compared with biventricular pacing in patients with pacing-induced cardiomyopathy: Results of a propensity score-matched analysis from a multicenter registryPietro Palmisano, Gabriele Dell'Era, Matteo Ziacchi, et al.
Heart Failure Reviews|November 17, 2022
Right heart failure in left heart disease: imaging, functional, and biochemical aspects of right ventricular dysfunctionStefano Ghio, Mauro Acquaro, Piergiuseppe Agostoni, et al.
ESC Heart Failure|March 17, 2026
Long-term outcomes following Sacubitril/Valsartan therapy for chronic HFrEF. Italian Real-World Multicenter StudyGiuseppe Dattilo, Roberto Licordari, Egidio Imbalzano, et al.
Pageof 10